Impact of adherence to statins on coronary artery disease in primary prevention.
about
Statin adherence and risk of acute cardiovascular events among women: a cohort study accounting for time-dependent confounding affected by previous adherenceUnmet Needs in LDL-C Lowering: When Statins Won't Do!Association between adherence to calcium-channel blocker and statin medications and likelihood of cardiovascular events among US managed care enrollees.Will cardiovascular disease prevention widen health inequalities?Evaluation of skeletal muscle during calf exercise by 31-phosphorus magnetic resonance spectroscopy in patients on statin medications.Impact of statin adherence on cardiovascular disease and mortality outcomes: a systematic reviewThe impact of statins on biological characteristics of stem cells provides a novel explanation for their pleiotropic beneficial and adverse clinical effects.Statin adherence and the risk of major coronary events in patients with diabetes: a nested case-control study.Long-term statin treatment in children with familial hypercholesterolemia: more insight into tolerability and adherence.Quantifying the contribution of statins to the decline in population mean cholesterol by socioeconomic group in England 1991 - 2012: a modelling studyThe burden of non-adherence to cardiovascular medications among the aging population in Australia: a meta-analysis.How patient cost-sharing trends affect adherence and outcomes: a literature review.Lipid-lowering drugs as primary prevention in general practice: do patients reach guideline goals and continue treatment? ADDITION DenmarkImpact of partial reimbursement on hepatitis B antiviral utilization and adherencePredictors of nonadherence to statins: a systematic review and meta-analysis.Driving forces behind increasing cardiovascular drug utilization: a dynamic pharmacoepidemiological model.Non-adherence to statin therapy: a major challenge for preventive cardiology.When compliance is an issue-how to enhance statin adherence and address adverse effects.Statins and Nonadherence: Should We RELATE Better?A systematic review to assess adherence and persistence with statins.The Medicines Advice Service Evaluation (MASE): a randomised controlled trial of a pharmacist-led telephone based intervention designed to improve medication adherence.Adherence to cardiovascular prevention strategies in patients with rheumatoid arthritis.The economic consequences of non-adherence to lipid-lowering therapy: results from the Anglo-Scandinavian-Cardiac Outcomes Trial.Adherence to preventive statin therapy according to socioeconomic position.Impact of out-of-pocket expenses on discontinuation of statin therapy: a cohort study in Finland.Relationships between Medication Adherence and Cardiovascular Disease Risk Factor Control in Elderly Patients with Diabetes.Predicting non-adherence in patients with familial hypercholesterolemia.Adherence to nucleos(t)ide analogues for chronic hepatitis B in clinical practice and correlation with virological breakthroughs.Risk factors control for primary prevention of cardiovascular disease in men: Evidence from the Aragon Workers Health Study (AWHS).
P2860
Q24658518-8684715F-5BD1-45E6-8C4F-528C9BE3E3EEQ26741705-37B88DAD-846D-43C5-A9EA-DD4A292652FBQ33610927-52DEB7D7-8B87-43AC-9935-54F57FD32C6BQ33682023-01CB2F95-5689-417B-A865-2143B68661EAQ34155702-D2B6D805-4172-4927-A73B-12880B84BCD7Q34554376-16D6D239-D029-4A39-8CE0-A17FBCBF8895Q34671958-4ED2BCC2-6CA5-4A33-B078-046680EB4570Q34976504-7CF37CB5-698E-4921-9D6D-235968A6E726Q35214678-813A0ED4-8C52-44E1-9860-A627DDA23426Q35347493-1ED309D7-40E5-4A86-BA45-94F4E396F965Q35573404-E2FB49F2-88CE-4CA4-93AB-DE30E0D445CEQ35752951-24E56F68-147D-42DF-9805-0985275BB1D7Q35841418-7BE5A9E4-3DE0-4EED-B8A1-143548C23DD8Q35992395-13039C60-8D5F-40BD-89DE-BBC0835C68CDQ36809178-1706DD28-E4E4-4773-B88D-96711F9777BDQ37175807-D6FF4D54-0BB5-46BA-BA77-12C38D03D2CEQ37642755-4662F33C-5211-4AC0-8D28-025FF164F69CQ38269606-6B56714F-9E83-4273-8BB0-1E2CDD83FD97Q38398011-23997160-EB49-4772-860C-8AD1DAA8AEB0Q39026831-86158A58-B0E0-49B8-85F2-50FAA18E447CQ40119227-15791005-9BB6-4299-83F9-E8F6BA964C64Q40742537-7D014F12-5B02-4299-8D31-88B9EA0B38F3Q42661766-D6E8C28A-526F-4A83-BE16-BD0B28555FD7Q44003644-F1D13339-7F97-4ACB-AB8B-4757E055638CQ44871003-74329360-BFDC-49A5-B321-169050B58347Q45933478-B47EB10F-0754-4914-A614-267C1F7ADC24Q49099766-CAE2176A-D041-4305-AB3C-F4719DE8BD9AQ51178953-F687B36F-2377-4206-9215-61C3EDF70400Q55022412-90F9398A-1A31-4D19-8B69-744765EFC4A9
P2860
Impact of adherence to statins on coronary artery disease in primary prevention.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Impact of adherence to statins on coronary artery disease in primary prevention.
@ast
Impact of adherence to statins on coronary artery disease in primary prevention.
@en
type
label
Impact of adherence to statins on coronary artery disease in primary prevention.
@ast
Impact of adherence to statins on coronary artery disease in primary prevention.
@en
prefLabel
Impact of adherence to statins on coronary artery disease in primary prevention.
@ast
Impact of adherence to statins on coronary artery disease in primary prevention.
@en
P2093
P2860
P1476
Impact of adherence to statins on coronary artery disease in primary prevention.
@en
P2093
Alice Dragomir
Anick Bérard
Danielle Pilon
Lucie Blais
Marie-Hélène Bouchard
Sylvie Perreault
P2860
P304
P356
10.1111/J.1365-2125.2006.02828.X
P407
P577
2007-01-03T00:00:00Z